BOCH
CEROW

Blue Owl Capital Holdings’s CERo Therapeutics Warrants CEROW Stock Holding History

Blue Owl Capital Holdings’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-224,930
Closed -$2.99K – 88
2025
Q3 		$2.99K Hold
224,930
– – ﹤0.01% 66
2025
Q2 		$5.35K Hold
224,930
– – ﹤0.01% 66
2025
Q1 		$2.25K Hold
224,930
– – ﹤0.01% 71
2024
Q4 		$2.25K Hold
224,930
– – ﹤0.01% 75
2024
Q3 		$2.25K Buy
+224,930
New +$3.73K ﹤0.01% 103

Other funds holding CEROW

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Blue Owl Capital Holdings's CEROW Position: Q4 2025 in Review

Blue Owl Capital Holdings sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 224,930 shares — an estimated $2.99K sold.

Blue Owl Capital Holdings first reported a position in CEROW in Q3 2024 and held it in 5 quarters. The position peaked at $5.35K in Q2 2025. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

  • Blue Owl Capital Holdings reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
  • Blue Owl Capital Holdings sold 224,930 CERo Therapeutics Warrants shares in Q4 2025, an estimated $2.99K.
  • Blue Owl Capital Holdings first reported a position in CERo Therapeutics Warrants in Q3 2024 and held it in 5 quarters.
  • Blue Owl Capital Holdings's CERo Therapeutics Warrants position peaked at $5.35K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Blue Owl Capital Holdings's 13F filing for Q4 2025, filed 9 Feb 2026.